Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
66 /100
HIGH RISK
Score updated Aug 28, 2026

LEXX — Lexaria Bioscience Corp. Dilution Risk Tracker

Track LEXX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LEXX — Get alerts when the score changes →

As of August 28, 2026, Lexaria Bioscience Corp. (LEXX) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. Lexaria Bioscience Corp. has a market capitalization of $14.92M, 24.79M shares outstanding, 28 institutional holders tracked. Stored dilution-related fields include 2.05M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
30
🔄 Convertible Debt
35

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 40%
🔄 Reverse Split model est. 65%
• 50-day avg $0.78 below $1 exchange minimum
• 7 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
📜 Warrant Exercise model 15%
• Warrant overhang: 8.3% of shares outstanding
🔔 Track LEXX — Get forecast alerts →

Market Data

Market Cap$14.92M
Shares Outstanding24.79M
Float23.44M
Cash$3.64M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 0.7% shares (2026Q1 vs prior)
28 institutional holders · 1.71M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 444.6K shares
#2 Invenomic Capital Management LP 442.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 294.2K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest244.0K
Days to Cover1.4
% of Float1.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-05-31
xbrl XBRL CONVERTIBLE 2017-08-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LEXX Dilution Snapshot

Lexaria Bioscience Corp. (LEXX) has a DilutionScore of 66/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LEXX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LEXX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LEXX
LEXX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.